Continuous subcutaneous insulin infusion (CSII) has become an indispensable modality in the management of type 1 diabetes. This therapy employs an insulin pump to deliver both basal and bolus doses, ...
NovoLog is a mealtime (rapid-acting) insulin. It’s a brand-name form of insulin aspart. For type 1 diabetes, you’ll typically inject NovoLog before your meals throughout the day. For type 2 diabetes, ...
Please provide your email address to receive an email when new articles are posted on . Click here to read the Cover Story, "Providers, regulators explore type 2 therapies for type 1 diabetes." An ...
– Late-breaking Phase III results show subcutaneous injection was non-inferior to intravenous infusion based on Ocrevus levels in the blood over 12 weeks – – Ocrevus subcutaneous injection was ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Sodium Chloride 0.9% Intravenous Infusion contains the active ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results